Kravtsov, Dmytro et al. published new progress in experiments with the help of cas: 5805-39-0

2-(1H-Benzo[d]imidazol-2-yl)aniline(cas:5805-39-0 Recommanded Product: 5805-39-0) is a chemical reagent used in the synthesis of small molecule inhibitors targeting ubiquitin-like domains for treatments of diseases caused by the cellular accumulation of damaged proteins.

Kravtsov, Dmytro published 《Oxidation of some benzyl substituted fused quinazoline derivatives》 in 2019. The article was appeared in 《Organic Communications》. They have made some progress in their research.Recommanded Product: 5805-39-0 The article mentions the following:

In this study, synthesis of some benzoyl substituted fused quinazoline derivatives e.g., I, using Fieser’s reagent, was reported. An unexpected product fused quinazolinone and BzOH were isolated from the reaction mixture Based on the exptl. data, a possible oxidation mechanism of ketone I with chromium trioxide was described. The experimental procedure involved many compounds, such as 2-(1H-Benzo[d]imidazol-2-yl)aniline (cas: 5805-39-0) .

2-(1H-Benzo[d]imidazol-2-yl)aniline(cas:5805-39-0 Recommanded Product: 5805-39-0) is a chemical reagent used in the synthesis of small molecule inhibitors targeting ubiquitin-like domains for treatments of diseases caused by the cellular accumulation of damaged proteins.

Reference:
Imidazole – Wikipedia,
Imidazole | C3H4N2 – PubChem